Department of Cardiology, BP Koirala Institute of Health Sciences, Dharan, Nepal.
Swiss Med Wkly. 2011 Apr 13;141:w13174. doi: 10.4414/smw.2011.13174. eCollection 2011.
The burden of ischemic heart disease (IHD) in developing countries is on the rise, due to urbanisation, industrialisation and the low availability of evidence based therapies and interventions.
Data was collected on consecutive patients admitted with acute coronary syndrome (ACS), from 1st January to 31st December 2008, to a tertiary care centre in eastern Nepal. Final diagnosis, risk factors, educational status, time delays, treatment and in-hospital outcomes were evaluated.
A total of 153 patients with ACS were admitted in 2008: 58 with ST elevation myocardial infarction (STEMI) (38%), 28 with non-ST elevation myocardial infarction (NSTEMI) (18%) and 67 with unstable angina (UA) (44%). 40% of patients with STEMI presented within 12 hours of symptom onset. Most patients presented late and 33% of them presented after 2 days or more. Over half the patients were not literate. Due to the unavailability of percutaneous coronary intervention (PCI) at the centre, thrombolysis with Streptokinase was considered for patients presenting with STEMI up to 24 hours after symptom onset. However, due to financial constraints, only 53% of patients in this broadened time window actually received thrombolytic treatment. The in-hospital mortality was 14% for all patients with ACS, and 17% for the patients with STEMI.
Only a small proportion of patients with ACS in Eastern Nepal are admitted to hospital, and those who are often arrive late, or cannot afford optimal medical management. Awareness, better referral and transport facilities, financial support for the needy, and the availability of on-site coronary angiography and angioplasty for selected patients should contribute to treat more ACS patients and improve their prognosis.
发展中国家的缺血性心脏病(IHD)负担正在上升,这是由于城市化、工业化以及缺乏循证治疗和干预措施所致。
收集了 2008 年 1 月 1 日至 12 月 31 日期间在尼泊尔东部一家三级护理中心因急性冠脉综合征(ACS)入院的连续患者的数据。评估了最终诊断、危险因素、教育程度、时间延迟、治疗和住院结果。
2008 年共收治 153 例 ACS 患者:58 例 ST 段抬高型心肌梗死(STEMI)(38%),28 例非 ST 段抬高型心肌梗死(NSTEMI)(18%)和 67 例不稳定型心绞痛(UA)(44%)。40%的 STEMI 患者在症状发作后 12 小时内就诊。大多数患者就诊较晚,其中 33%在发病后 2 天或更晚就诊。超过一半的患者没有文化。由于中心无法进行经皮冠状动脉介入治疗(PCI),对于发病后 24 小时内的 STEMI 患者,考虑使用链激酶进行溶栓治疗。然而,由于资金限制,在这个扩大的时间窗口内,实际上只有 53%的患者接受了溶栓治疗。所有 ACS 患者的住院死亡率为 14%,STEMI 患者的住院死亡率为 17%。
尼泊尔东部只有一小部分 ACS 患者住院治疗,而且这些患者通常就诊较晚,或者无法负担最佳的医疗管理。提高认识、更好的转诊和交通设施、为贫困患者提供经济支持,以及为选定患者提供现场冠状动脉造影和血管成形术,应有助于治疗更多的 ACS 患者并改善其预后。